T.J. Quinn and Mike Fish of ESPN.com report that the spokeswoman for Robinson Cano’s charitable foundation was named in the documents of Biogenesis, the now defunct Miami anti-aging clinic which has launched an investigation by Major League Baseball into players’ alleged use of performance enhancing drugs:
The spokeswoman for Robinson Cano’s foundation is listed as having been a client of the Biogenesis clinic last summer, although she denies having received anything from the clinic and says Cano “definitely never did.”
Major League Baseball, however, has possession of a Biogenesis client roster that lists the spokeswoman, Sonia Cruz, and is investigating whether Cano had any relationship to the clinic, sources familiar with MLB’s investigation told “Outside the Lines”.
There are the requisite denials all around. Quinn and Fish note, however, that Cano is close with both Melky Cabrera and Alex Rodriguez, who have also been implicated in the Biogenesis scandal.
Which would normally not be all that important nor would it serve as a reasonable basis for Major League Baseball to pursue its investigation, but guilt-by-association is pretty much all anyone has in this whole shebang, so Cano should probably consider himself in the same crosshairs as everyone else who has thus far been named.
UPDATE: Worth noting, as I neglected to when I posted this a moment ago, that Quinn and Fish’s sources say that Sonia Cruz’s interaction with Biogenesis, as reflected in the records they’ve obtained, is consistent with her claim that she went to Biogenesis for personal weight loss purposes. Which would seem to be pretty relevant here. As they also report, however, Major League Baseball is still investigating Cano all the same.
CC Sabatha made headlines in October when he abruptly left the Yankees to go into alcohol rehab. After a month there he came back and gave interviews about his decision and his battle with the bottle and then disappeared into the offseason the way most players do.
He emerged the other day and spoke with the New York Daily News’ Mark Feinsand and says that he’s ready for baseball once again. Indeed, in some ways he’s more ready now than he usually is by mid February. He’s been throwing bullpen sessions for the past three weeks — he normally waits until he gets to Tamps — and he says his troublesome knee is feeling good.
Sabathia will turn 36 during the season. In 2015 he was 6-10 with a 4.73 ERA in 29 starts and posted his lowest strikeout rate in a decade. Late in the season, however, with the help of a knee brace, he was at his most effective in some time. He won’t need to return to 2008 form in order to help the Yankees this season, but he will need to look more like he did in September if he is to help the Yankees to the playoffs.
The Mets are currently enjoying the spoils of the best young rotation in the game, but the big question is whether this is just a brief window or the start of sustained success. Given the huge prices on the free agent market, it’s going to be next to impossible to keep the band together, but at least one member of the rotation is open to sticking around for the long-term.
While there haven’t been any talks yet, All-Star right-hander Jacob deGrom told Kevin Kernan of the New York Post that he could see himself discussing an extension with the Mets.
“I’m a little bit older, so I might be more willing to do something like that,’’ deGrom told The Post at Mets pre-camp. “You just have to look at what is fair so both sides get a decent deal. It’s something I’d have to look into and make sure I agree with it.’’
It makes sense from deGrom’s perspective. He broke into the majors later than most prospects, so he’ll be 28 this June. Depending on whether he qualifies as a Super Two, he’ll be arbitration-eligible for the first time after either 2016 or 2017. Either way, he’s under team control through 2020, which means that he’s currently on track to hit free agency after his age-32 season. The market might not be kind to him even if he manages to stay healthy, so it could behoove him to get as much guaranteed money as possible right now. The Mets could always decide to play things year-to-year, but perhaps deGrom would be willing to settle for a discount in order to get them to buy out a free agent year or two. It’s a really interesting situation to think about, but odds are the two sides will wait on contract talks until he’s arbitration-eligible for the first time.
DeGrom owns a 2.61 ERA in 52 starts over his first two seasons in the majors. Among starters, only Zack Greinke, Jake Arrieta, and Clayton Kershaw have a lower ERA since the start of 2014.
The Royals and third baseman Mike Moustakas have avoided arbitration by agreeing to a two-year, $14.3 million deal, reports Jon Heyman of MLB Network.
The deal, which was initially discussed last month, buys out Moustakas’ final two years of arbitration. Jeffrey Flanagan of MLB.com reports that it’s believed he’ll make $5.6 million in 2016 and $8.7 million in 2017.
The 27-year-old Moustakas posted an underwhelming .668 OPS over his first four seasons in the majors, but he enjoyed a big postseason in 2014 before breaking out last season by batting .284/.348/.470 with 22 home runs and 82 RBI.
ESPN’s Jerry Crasnick reported this morning that free agent reliever Tommy Hunter required core muscle repair surgery earlier this offseason. Coming off a disappointing 2015, it’s understandable why he’s still on the market, but it sounds like he has at least one significant lead.
Marc Topkin of the Tampa Bay Times hears that the Rays are having “advanced talks” with Hunter as they attempt to add an experienced arm to their bullpen. Nothing is considered close and Hunter is also talking to other clubs. Meanwhile, the Rays have been in touch with veteran reliever Ryan Webb while monitoring the trade market.
Hunter posted a 2.88 ERA as a late-inning arm from 2013-2014, but he compiled a mediocre 4.18 ERA over 58 appearances last season between the Orioles and Cubs. On the bright side, his velocity has held steady and his control is still very good. Despite the down year and core muscle surgery, Topkin writes that Hunter may be holding out for a multi-year deal.